Imunon, Inc. Unrealized Gain (Loss) on Investments
Imunon, Inc. (IMNN) reported Unrealized Gain (Loss) on Investments of -$34.30 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2024-03-28
- Imunon, Inc. unrealized gain (loss) on investments for the quarter ending 2023-12-31 was -$40.36K.
- Imunon, Inc. unrealized gain (loss) on investments for the quarter ending 2023-09-30 was $141.61K.
- Imunon, Inc. unrealized gain (loss) on investments for the quarter ending 2022-12-31 was -$51.92K.
- Imunon, Inc. unrealized gain (loss) on investments for the quarter ending 2022-09-30 was -$44.61K.
- Imunon, Inc. unrealized gain (loss) on investments for fiscal 2023 was -$34.30K.
- Imunon, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$34.47K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$40.36K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $101.25K derived: sum of 2 quarters · filed 2024-03-28 | -$34.30K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $141.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.06K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | -$135.55K 10-Q · filed 2023-08-10 | |||
| 2022-12-31 | -$51.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$96.53K derived: sum of 2 quarters · filed 2024-03-28 | -$34.47K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$44.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $17.45K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $62.06K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |